Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

2.78
Delayed Data
As of Dec 07
 0.00 / 0.00%
Today’s Change
2.35
Today|||52-Week Range
9.07
-65.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues4.7M7.1M5.9M5.2M
 
 
 
 
 
Cost of Goods Sold2.8M1.4M1.7M1.3M
 
 
 
 
 
Depreciation And Amortization546.0K528.0K750.0K853.0K
 
 
 
 
 
 
Operating ExpensesGross Income1.4M5.1M3.5M3.0M
 
 
 
 
 
General Expenses8.3M6.3M8.0M7.2M
 
 
 
 
 
Research And Development62.0K0.000.000.00
 
 
Total Operating Expenses11.7M8.2M10.4M9.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.0M-1.1M-4.5M-4.1M
 
 
 
 
 
Extraordinary Charge0.000.00-1.4M0.00
 
 
Interest Expense On Debt484.0K405.0K445.0K865.0K
 
 
 
 
 
Other Expenses-305.0K347.0K-1.1M-203.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.8M-1.2M-7.4M-5.2M
 
 
 
 
 
Income Taxes-360.0K-45.0K-94.0K-88.0K
 
 
 
 
 
Net Income-7.4M-1.2M-7.5M-5.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.1M20.3M20.4M28.4M
 
 
 
 
 
Shares To Calculate EPS Diluted20.1M20.3M20.4M28.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.37-$0.06-$0.37-$0.19
 
 
 
 
 
EPS Diluted-$0.37-$0.06-$0.37-$0.19